Pulmonary tularaemia in a female adolescent with inflammatory bowel disease receiving infliximab: Do not miss the diagnosis

Pediatr Pulmonol. 2023 Mar;58(3):980-982. doi: 10.1002/ppul.26275. Epub 2022 Dec 20.

Abstract

We report the first described case of pulmonary tularaemia in the pediatric patient receiving infliximab for ulcerative colitis. We highlight the importance of considering Francisella tularensis in diagnostically challenging cases of persistent respiratory symptoms to facilitate early diagnosis and adequate therapy. The TCR-γδ + DN T cells are gaining important role in clinical practice. Polymerase chain reaction assays and serology guarantee early recognition.

Keywords: double negative T-lymphocytes; infliximab; paediatrics; pulmonary tularaemia; ulcerative colitis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Female
  • Francisella tularensis* / genetics
  • Humans
  • Inflammatory Bowel Diseases* / diagnosis
  • Inflammatory Bowel Diseases* / drug therapy
  • Infliximab / adverse effects
  • Polymerase Chain Reaction
  • Tularemia* / diagnosis
  • Tularemia* / drug therapy

Substances

  • Infliximab